If your lead volume looks healthy, your cost per lead looks fine, and your revenue has not moved in a year, the problem is almost never the top of the funnel. It is the number of first-time patients who never came back, and most practices have never measured it.
The number is your 90-day return rate: of the patients who visited your practice for the first time in a given month, what percentage completed a second visit within 90 days. It takes under an hour to pull. It predicts revenue more reliably than lead volume, cost per lead, or anything your ad dashboard reports.
Why new patient numbers look fine and revenue does not
Growth in aesthetics is mostly not a new-patient story. Most of the revenue in a mature practice comes from patients who already know you, because the treatments that drive aesthetics revenue run on cycles and the same person returns several times a year.
Read that in reverse and you have the reader's problem exactly. If existing patients are where the revenue lives, and your existing patient base is not compounding, then new patients can climb all year and the revenue line will sit flat. You are refilling a bucket, not growing one.
The leak is the one-and-done patient. A large share of first-time patients at a typical practice never book a second appointment. That is not a marketing failure. That is a practice that acquired a patient, delivered a treatment, and then let the relationship end at the front desk.
The economics have been understood for decades outside aesthetics. Winning a new customer costs considerably more than keeping one you already have. The aesthetics-specific version is sharper, because your treatments have natural cycles. A patient who does not rebook is not neutral. They are a paid-for asset you wrote off.
How to pull your 90-day return rate this afternoon
You do not need new software. You need one report out of your practice management system and a spreadsheet.
- Pick a month that is at least four months in the past. Say, six months ago.
- Export every patient whose first completed appointment at your practice falls in that month. First visit, not first booking. This is your cohort.
- For each of those patients, check whether they completed a second appointment within 90 days of that first visit.
- Divide the second group by the first. That is your 90-day return rate for that cohort.
Three rules decide whether the number is honest. Count patients, not visits, or your regulars will flatter the result. Count completed appointments, not bookings, or no-shows will inflate it. Exclude retail-only purchases, because a product sale is not a return visit.
Then repeat it for each of the last six months and put the six numbers in a row. The trend matters more than any single month, and a cohort view is the whole point. Blended retention across your entire patient list is a vanity number, because loyal regulars mask new patients bleeding out. Cohorts by first-visit month are where the leak becomes visible.
What good actually looks like
You have probably seen med spa retention benchmarks quoted in industry content. Treat them carefully. Most circulate without a measured dataset behind them, and owners who benchmark against them either conclude they are failing when they are average, or stop looking.
The more useful benchmark is your own trend. Pull six consecutive cohorts and judge the direction. A return rate climbing month over month means the rebooking habit is taking hold. A flat or falling line means the leak is structural, not seasonal. Wellness and membership-led models, where the treatment plan itself assumes repeat visits, will always sit above injectable-only or one-off treatment practices, so compare yourself to the practice you were last quarter rather than to a number in a trade article.
The spread between a practice that rebooks well and one that does not is the entire argument of this article. Two practices can run identical ad accounts with identical cost per lead and end the year with completely different P&Ls.
The three moments a first-time patient decides to come back
Retention is not a program. It is three specific moments, and most practices lose at the first one.
The rebooking ask at checkout. The strongest predictor of a second visit is whether the patient left with one on the calendar. This is a front desk behaviour, not a campaign. It has to be scripted, expected, and tied to the clinical cycle. A neurotoxin patient is on a roughly three to four month rhythm, which is exactly why 90 days is the right clock in aesthetics. The ask is not a sell. It is clinical continuity, and it should sound like it.
The first 14 days after treatment. This is where results settle, anxiety peaks, and the patient privately decides whether you were worth it. Silence here reads as indifference. A check-in, aftercare guidance, and an easy route to a question are the difference between a patient who tells friends and a patient who quietly tries someone else.
The 60-day gap. A patient with no future appointment and no contact for two months is functionally churned, they just have not noticed yet. Reaching them at day 60 with something relevant to their treatment history is reactivation while it is still cheap. Reaching them at day 300 is acquisition at full price.
Automate what scales, let the front desk own what matters
Email and SMS should carry the volume and the timing. Post-treatment aftercare sequences, cycle-timed reminders mapped to each treatment's natural interval, 60-day gap reactivation, membership and package nudges, review requests at the right point in the journey. These run every day whether or not anyone remembers, and SMS in particular reaches patients who will never open an email.
What automation cannot do is make the rebooking ask at checkout, hold a nervous patient's confidence at day 10, or respond to an inbound enquiry in minutes. Speed of response decides how many enquiries ever become consults, and in aesthetics most bookings still involve a human on the phone. Give your front desk the scripts and the protected time, and automate everything around them.
Two adjacent leaks read as retention problems but are not. No-shows and late cancellations quietly consume calendar capacity you have already paid to fill. Measure both before you blame the marketing.
One more lever worth naming. Memberships and treatment packages convert a decision the patient has to make every few months into one they made once, which is why practices that run them well tend to see higher spend and stronger retention from those patients.
The ratio to run every quarter
Once a quarter, put two numbers side by side.
Revenue per patient over 12 months. Total revenue from a first-visit cohort, tracked for a full year, divided by the number of patients in it.
Ad spend per patient. Total media and agency spend for that period divided by new patients acquired.
Acquisition cost varies enormously by model, with injectable practices running on referral flow at one end and consult-led surgical and body contouring practices at the other, so your own ratio is the only one that matters. If 12-month revenue per patient is not multiples of acquisition cost, more ad spend will not fix it, it will just make the leak more expensive.
Run that ratio, and the growth question answers itself. Practices that fix the second visit before they scale spend get both. Practices that scale first pay twice.
We work only with aesthetic practices, which is why our audits start with the retention cohort rather than the ad account, and why email automation, SMS reactivation and the front desk workflow sit alongside the campaigns rather than after them. If your new patient numbers look fine and your revenue does not, that is the conversation worth having.
Frequently asked questions
What exactly is a 90-day return rate and how is it different from retention rate?
A 90-day return rate measures one cohort: patients whose first completed visit happened in a given month, and what share of them completed a second visit within 90 days. A general retention rate blends your whole patient list, which lets loyal regulars mask new patients who never came back. The cohort version is the sensitive number, because it isolates the group you just paid to acquire.
What is a good 90-day return rate for a med spa?
Measured operator data puts the median new-client 90-day return rate at 45.8%, with the 25th percentile at 36% and the 75th at 62%. Pure aesthetics brands tend to cluster between 35% and 55%, while wellness-led recurring models reach the top of the range. Higher benchmarks circulate in industry content without a measured dataset behind them, so do not judge yourself against those.
My cost per lead is low. Why is my revenue still flat?
Because most aesthetics revenue comes from existing patients, not new ones. In benchmark data, the median brand grew revenue 19.2% year over year while new-customer growth was 1.2%, and around 70% of revenue came from existing clients. If 43.9% of your patients visit once, as happens at the median brand, you can buy leads efficiently all year and still flatline.
What should be automated and what should the front desk handle?
Automate the volume and the timing: post-treatment aftercare, cycle-timed reminders matched to each treatment's natural interval, 60-day gap reactivation, and review requests. The front desk owns the rebooking ask at checkout, the human check-in when a patient is anxious, and speed on inbound enquiries. In aesthetics most bookings still involve a human on the phone, so that is where the revenue is decided.
How long does it take to measure this?
Under an hour. Export every patient whose first completed appointment fell in a month at least four months ago, check how many completed a second appointment within 90 days, and divide. Count patients not visits, completed appointments not bookings, and exclude retail-only purchasers.
